Clinical Practice Guidelines Example Implementation Guide - Anthrax Post-Exposure Prophylaxis
1.1.0 - ci-build International flag

Clinical Practice Guidelines Example Implementation Guide - Anthrax Post-Exposure Prophylaxis, published by HL7 International - Clinical Decision Support WG. This guide is not an authorized publication; it is the continuous build for version 1.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/cpg-example-anthrax/ and changes regularly. See the Directory of published versions

DetectedIssue: Vaccine History Inconsistencies Detected Issue

Generated Narrative: DetectedIssue vaccine-history-inconsistencies-detected-issue

status: Preliminary

code: Not equivalent alert

author: Device: identifier = Anthrax_Post_Exposure_Prophylaxis_FHIRv400.cql; manufacturer = Centers for Disease Control and Prevention; type = Clinical data collection/management information system application software (physical object); url = http://cqframework.org/cpg-example-anthrax/Device/anthrax-example-device

implicated: MedicationRequest: status = active; intent = proposal; medication[x] = Ciprofloxacin 500 MG Oral Tablet

detail: The patient has an active prescription for [Ciprofloxacin]. Evaluate the dosage and duration to ensure a 60-day regimen of appropriate antibiotic post-anthrax exposure: [Ciprofloxacin 500 mg by mouth every 12 hours for 60 days].

Mitigations

-Action
*Medication review due (situation)